Clinical studies recruiting near Ottawa

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Ottawa Hospital Research Institute · Joseph Broderick, MD · NCT07227246 Brain Imaging of Cognition Inn Schizophrenia and Depression
Phase N/A · Royal Ottawa Mental Health Center · The Royal Ottawa Mental Health Centre · NCT04159662 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · The Ottawa Hospital - General Campus ( Site 0102) · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · The Ottawa Hospital Cancer Centre · Bristol-Myers Squibb · NCT07106762 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · The Ottawa Hospital - General Campus ( Site 0414) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Illinois CancerCare-Ottawa Clinic · National Cancer Institute (NCI) · NCT05564390 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · Children's Hospital of Eastern Ontario · National Cancer Institute (NCI) · NCT06172296 Comparing the Efficacy of fMRI-Guided vs. Standard iTBS in Treating Depression
NA · The Royal's Institute of Mental Health Research · The Royal Ottawa Mental Health Centre · NCT06152705 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Illinois CancerCare-Ottawa Clinic · NRG Oncology · NCT05624996 The DRAGON 2 Trial
NA · The Ottawa Hospital · Maastricht University · NCT05428735 Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction
Phase 2 · Ottawa Hospital Research Institute · Population Health Research Institute · NCT04680442 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Clinical Site · ADARx Pharmaceuticals, Inc. · NCT06960213 Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease
Phase 1 · The Ottawa Hospital · Ottawa Hospital Research Institute · NCT07177833 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop
Phase 3 · Ottawa Hospital Research Institute · Hoffmann-La Roche · NCT06793215 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · Children's Hospital of Eastern Ontario · The Hospital for Sick Children · NCT06560606 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Illinois CancerCare-Ottawa Clinic · Alliance for Clinical Trials in Oncology · NCT07321652 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · Children's Hospital of Eastern Ontario · PedAL BCU, LLC · NCT05183035 Randomization of Single vs Multiple Arterial Grafts
NA · University of Ottawa Heart Institute Canada · Weill Medical College of Cornell University · NCT03217006 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · Children's Hospital of Eastern Ontario · National Cancer Institute (NCI) · NCT05691478 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Illinois CancerCare-Ottawa Clinic · Alliance for Clinical Trials in Oncology · NCT07091617 Left Atrial Imaging Prior to Cardioversion: Leveraging Computed Tomography to Rule Out Thrombus in The Emergency Departm
NA · The Ottawa Hospital Civic Campus · Ottawa Heart Institute Research Corporation · NCT07002450 A Platform Trial for Gram Negative Bloodstream Infections
NA · The Ottawa Hospital · Sunnybrook Health Sciences Centre · NCT06537609 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 2204 · Turning Point Therapeutics, Inc. · NCT03093116 Catheter Ablation Versus Radio-Ablation for Ventricular Tachycardia: a Randomized Controlled Trial
Phase 3 · University of Ottawa Heart Institute · Ottawa Heart Institute Research Corporation · NCT05047198 A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Dia
Phase 3 · Centricity Research Ottawa LMC Endocrinology · Eli Lilly and Company · NCT07222332 Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of
Phase 4 · The Ottawa Hospital Cancer Centre · Ottawa Hospital Research Institute · NCT05753618 Transcatheter Mitral Valve Repair for Inotrope Dependent Cardiogenic Shock
NA · University of Ottawa Heart Institute · Ottawa Heart Institute Research Corporation · NCT05298124 Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma
Phase 2 · Ottawa Hospital Research Institute · Canadian Cancer Trials Group · NCT05998642 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Hospital of Eastern Ontario · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Illinois CancerCare-Ottawa-Fox River Cancer Center · Pfizer · NCT07144280

Look up another city

Look up another condition